EYENOVIA INC (EYEN) Stock Price, Quote, News and Overview
NASDAQ:EYEN - Nasdaq - US30234E1047 - Common Stock - Currency: USD
EYEN Quote, Performance and Key Statistics
1.68
-0.05 (-2.89%)
The current stock price of EYEN is 1.68 USD. In the past month the price decreased by -61.25%. In the past year, price decreased by -98.76%.
EYEN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 67.21 | 829.40B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 27.53 | 390.99B | ||
| JNJ | JOHNSON & JOHNSON | 16.25 | 390.76B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 20.56 | 230.17B | ||
| MRK | MERCK & CO. INC. | 11.71 | 226.40B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.77 | 215.98B | ||
| PFE | PFIZER INC | 8.46 | 149.04B | ||
| SNY | SANOFI-ADR | 13.62 | 136.54B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.97 | 113.23B | ||
| GSK | GSK PLC-SPON ADR | 7.81 | 74.77B | ||
| ZTS | ZOETIS INC | 27.1 | 72.39B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.95 | 44.58B |
Related stock screener links
About EYEN
Company Profile
Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company is headquartered in New York City, New York and currently employs 57 full-time employees. The company went IPO on 2018-01-25. The company is focused on the commercialization of Mydcombi (tropicamide+phenylephrine ophthalmic spray) for mydriasis, as well as clobetasol propionate ophthalmic suspension 0.05% to reduce pain and inflammation following ocular surgery. Its product line includes Mydcombi, clobetasol propionate, and therapeutic programs, MicroPine and MicroLine. Mydcombi is its fixed combination formulation of tropicamide-phenylephrine for inducing mydriasis for diagnostic procedures and in conditions where short-term pupil dilation is desired. MicroPine is its topical therapy for the treatment of progressive myopia, a disease associated with pathologic axial elongation of the eye and sclero-retinal stretching. MicroLine is its investigational pharmacologic treatment for presbyopia, a non-preventable, age-related hardening of the lens.
Company Info
EYENOVIA INC
295 Madison Ave Ste 2400
New York City NEW YORK 10017 US
CEO: Tsontcho Ianchulev
Employees: 57
Company Website: https://eyenovia.com/
Investor Relations: http://ir.eyenovia.com/
Phone: 18137669539
EYENOVIA INC / EYEN FAQ
What is the stock price of EYENOVIA INC today?
The current stock price of EYEN is 1.68 USD. The price decreased by -2.89% in the last trading session.
What is the ticker symbol for EYENOVIA INC stock?
The exchange symbol of EYENOVIA INC is EYEN and it is listed on the Nasdaq exchange.
On which exchange is EYEN stock listed?
EYEN stock is listed on the Nasdaq exchange.
What is EYENOVIA INC worth?
EYENOVIA INC (EYEN) has a market capitalization of 3.51M USD. This makes EYEN a Nano Cap stock.
How many employees does EYENOVIA INC have?
EYENOVIA INC (EYEN) currently has 57 employees.
What are the support and resistance levels for EYENOVIA INC (EYEN) stock?
EYENOVIA INC (EYEN) has a resistance level at 1.92. Check the full technical report for a detailed analysis of EYEN support and resistance levels.
Is EYENOVIA INC (EYEN) expected to grow?
The Revenue of EYENOVIA INC (EYEN) is expected to grow by 103.02% in the next year. Check the estimates tab for more information on the EYEN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy EYENOVIA INC (EYEN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of EYEN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of EYEN, evaluating the profitability, health, valuation and growth aspects
- EYENOVIA INC (EYEN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- EYENOVIA INC (EYEN) Sales and EPS estimates to see what analysts future expectations are.
- EYENOVIA INC (EYEN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- EYENOVIA INC (EYEN) Insider and Institutional Ownership to learn about the owners and their transactions.
- EYENOVIA INC (EYEN) Stock Chart to make your own analysis
- EYENOVIA INC (EYEN) Latest news and press-releases to stay up to date.
Does EYENOVIA INC (EYEN) stock pay dividends?
EYEN does not pay a dividend.
When does EYENOVIA INC (EYEN) report earnings?
EYENOVIA INC (EYEN) will report earnings on 2025-03-17, after the market close.
What is the Price/Earnings (PE) ratio of EYENOVIA INC (EYEN)?
EYENOVIA INC (EYEN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-26.01).
EYEN Technical Analysis
EYEN Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to EYEN. EYEN may be in some trouble as it scores bad on both profitability and health.
EYEN Financial Highlights
Over the last trailing twelve months EYEN reported a non-GAAP Earnings per Share(EPS) of -26.01. The EPS decreased by -3840.91% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -165.95% | ||
| ROE | -1017.15% | ||
| Debt/Equity | 0.58 |
EYEN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 48% to EYEN. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of -7146.57% and a revenue growth 103.02% for EYEN